[1] |
Wu Linghong,Huang Tianren,Deng Wei,Huang Zhibi,Guo Jiao,Huang Yueying.
Meta-analysis:the relationship of hepatitis B virus genotypes,subgenotypes and hepato-cellular carcinoma in China
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(5): 365-370.
|
[2] |
Tan Baogao,Liu Biao.
The value of 3.0T MR arterial spin labeling in the diagnosis of early-stage primary liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(4): 310-313.
|
[3] |
Wang Jianwu, Yu Xiangyuan, Wang Qianqian, Qin Linyuan, Bei Chunhua,Tan Shengkui, He Songqing, Tang Bo, Liao Weijia, Yu Hongping.
Single nucleotide polymorphisms in DNA repair gene RAD52 miRNA target sequence and susceptibility to hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2018, 10(2): 99-104.
|
[4] |
Wei Feifei, Liao Yan, Zhao Ruiqiang, Wang Hongxue, Xie Yu'an.
ITGβ1 polymorphism and genetic susceptibility to hepatocellular carcinoma in families from the Zhuang community in Fusui County, Guangxi
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(5): 273-277.
|
[5] |
Bai,Qi Lunan,Chen Jie,Ye Jiazhou,Wu Feixiang,Peng Tao,Li Lequn.
Significance of p53 gene mutation and expression in human primary hepatocellular carcinoma in the presence of hepatitis B virus and aflatoxin B1
[J]. Chinese Journal of Oncology Prevention and Treatment, 2016, 8(1): 1-6.
|
[6] |
HUANG Xin-fei,LING Yong-chi,QI Lu-nan,OU Chao.
Proteomic analysis of aflatoxin B1-related hepatocellular carcinoma in the FuSui area of Guangxi,China
[J]. Chinese Journal of Oncology Prevention and Treatment, 2014, 6(3): 235-243.
|
[7] |
ZHANG Shi-jie,MA Yi-long,KANG Ping,MENG Zhi-bin,LI Zhi-kun,OU Sheng-qiu,QI Feng,ZHAO Chang.
Comparing the therapeutic efficacy of TACE combined with psychro-circulation percutaneous microwave coagulation therapy or radioactive 125I particle implantation to treat large primary liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2013, 5(3): 246-249.
|
[8] |
YE Xin-ping,PENG Tao,SHANG Li-ming,PENG Ning,LI Jia-mei,QIN Xiao,SU Zhi-xiong.
Clinical efficacy and toxicity of TACE combined with sorafenib in advanced hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2013, 5(3): 242-245.
|
[9] |
QIN Ying-rong,LIN Yuan,MO Xian-wei,LUO Han-zhuan,LIU Shao-ping.
Correlation of postoperative cellular immune function and recurrence in primary liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2013, 5(3): 235-238.
|
[10] |
QI Lu-nan,CHEN Yuan-yuan,CHEN Zu-sun, BAI Tao,ZHU Hai,PENG Tao,LI Le-qun.
Array-based comparative genomic hybridization analysis of patients with hepatocellular carcinoma related to hepatitis B virus and aflatoxin B1 exposure in Guangxi, China
[J]. Chinese Journal of Oncology Prevention and Treatment, 2013, 5(3): 201-210.
|
[11] |
WEI Wei,CAO Ji,OU Chao,LI Yuan.
Expression of AKR1B10 in hepatocellular carcinoma and its relationship with AFP level
[J]. Chinese Journal of Oncology Prevention and Treatment, 2013, 5(2): 110-113.
|
[12] |
HUANG Jian-lü,LIANG Yu,LIU Zheng-tao,LUO Chang-zhi,YU Long,WANG Dong-yang,LI Yuan,PENG Tao.
Validation of candidate single nucleotide polymorphisms associated with α-fetoprotein lev-els in human hepatoma cell lines
[J]. Chinese Journal of Oncology Prevention and Treatment, 2013, 5(2): 95-99.
|
[13] |
WANG Shi-jun,CHEN Jie,PENG Ning-fu,QI Lu-nan,XIANG Bang-de,HUANG Guo-xiong,LI Le-qun.
Correlated expression of E-cadherin and EpCAM in the gross morphology subtype of nodular hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2013, 5(1): 42-45.
|
[14] |
HUANG Wen-tao,WU Qiong,LI Jin-yuan,HUANG Yi,XU Heng.
Mutational analysis of the protein-coding sequence of the POLD1 gene in human hepato-cellular carcinoma cell line SMMC-7721
[J]. Chinese Journal of Oncology Prevention and Treatment, 2013, 5(1): 35-38.
|
[15] |
LU Hai-juan,LUO Xiao-ling,YUE Hui-fen,SHEN Xiao-yun,ZHANG Xue-rong,XIE Yu-an,WU Ji-ning.
Impact of fresh Gecko active component on proliferation and apoptosis of human hepato-cellular carcinoma cell line BEL-7404
[J]. Chinese Journal of Oncology Prevention and Treatment, 2013, 5(1): 28-31.
|